Detecting Necroptosis Activation via Exosome Analysis
Patents for licensing
Never miss an update from Yeda
Create your free account to connect with Yeda and thousands of other innovative organizations and professionals worldwide
Technology Offer
Detecting Necroptosis Activation via Exosome Analysis
- Yeda
- From Israel
- Responsive
- Patents for licensing
Summary of the technology
Numerous medical conditions are related to inflammation, such as pancreatitis, psoriasis, inflammatory bowel disease, atherosclerosis, neurodegeneration, and more. However, determination of inflammation in the body, especially at early stages of a pathology is difficult to assess. Therefore, there is a great clinical need for diagnostic tools to gauge inflammation.
The team of Prof. David Wallach have discovered novel biomarkers in exosomes related to necroptosis, a form of programmed cell death that induces inflammation. Using these biomarkers inexosomes different diagnostic tests can be developed for an array of inflammatory conditions.
Applications
- Diagnostics for inflammation
- Specificity in terms of tissue affected when combined with other biomarkers
Technology's Essence
Cell-derived vesicles termed exosomes are commonly found in bodily fluids such as blood and urine. Consequently, by examining these exosomes it is feasible to discover different biomarkers for the state of health in the human body. The Wallach team discovered that when the kinase RIPK3 is activated, a known inducer of inflammation and necroptosis, it also phosphorylates mixed lineage kinase domain like pseudokinase (MLKL) as one of its targets. Phosphorylated MLKL was then shown to increase exosome production, which led to a greater release of phosphorylated MLKL in said exosomes.
Therefore using in vitro work the Wallach team was able to show that screening exosomes for phosphorylated MLKL represents a potential diagnostic for inflammation.
Intellectual property status
- Granted Patent
- Patent application number :European Patent Office Published: Publication Number: 3500683
Related Keywords
About Yeda
Yeda ("Knowledge" in Hebrew) Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science (WIS) and is the second company of its kind established in the world.
WIS is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It was initially established as the Daniel Sieff Institute in 1934, by Israel and Rebecca Sieff of London in memory of their son Daniel. In 1949, it was renamed for Dr. Chaim Weizmann, the first President of the State of Israel and Founder of the Institute.
Yeda initiates and promotes the transfer to the global marketplace of research findings and innovative technologies developed by WIS scientists. Yeda holds an exclusive agreement with WIS to market and commercialize its intellectual property and generate income to support further research and education.
Since 1959 Yeda has generated the highest income per researcher compared to any other TTO worldwide. Weizmann has generated a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad, Erbitux, Vectibix, Protrazza, Humira, and recently the CAR-T cancer therapy Yescarta.
Yeda performs the following activities:
◣ Identifies and assesses research projects with commercial potential.
◣ Protects the intellectual property of WIS and its scientists.
◣ Licenses WIS' inventions and technologies to industry.
◣ Establishes new Startup companies based in WIS Intellectual Property
◣ Channels funding from industry to research projects.
Our portfolio covers a broad spectrum of the natural sciences, including:
◣ Agriculture and Plant Genetics, including Bio-fuels
◣ Chemistry and Nanotechnology
◣ Environmental Sciences and Solar Energy
◣ Mathematics and Computer Science
◣ Medical Devices
◣ Pharmaceuticals and Diagnostics
◣ Physics and Electro-Optics
◣ Research Tools
Related Technology Offers
Send a request for information
to Yeda
About Technology Offers
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Help
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
